6.08
price down icon1.94%   -0.12
after-market Handel nachbörslich: 6.10 0.02 +0.33%
loading

Immuneering Corp Aktie (IMRX) Neueste Nachrichten

pulisher
Dec 10, 2025

Top investors say Immuneering Corp (IMRX) ticks everything they need - setenews.com

Dec 10, 2025
pulisher
Dec 02, 2025

This trade activity should not be overlooked: Immuneering Corp (IMRX) - setenews.com

Dec 02, 2025
pulisher
Dec 01, 2025

Immuneering (IMRX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025
pulisher
Nov 27, 2025

We Think Immuneering (NASDAQ:IMRX) Can Afford To Drive Business Growth - Yahoo Finance

Nov 27, 2025
pulisher
Nov 26, 2025

Immuneering (IMRX) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Nov 26, 2025
pulisher
Nov 26, 2025

Wall Street Analysts See a 126.21% Upside in Immuneering (IMRX): Can the Stock Really Move This High? - Yahoo Finance

Nov 26, 2025
pulisher
Nov 25, 2025

Immuneering to Present at the Piper Sandler 37th Annual Healthcare Conference - The Manila Times

Nov 25, 2025
pulisher
Nov 24, 2025

Immuneering Corporation (IMRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Nov 24, 2025
pulisher
Nov 24, 2025

A new trading data show Immuneering Corp (IMRX) is showing positive returns. - Setenews

Nov 24, 2025
pulisher
Nov 22, 2025

Companies Like Immuneering (NASDAQ:IMRX) Are In A Position To Invest In Growth - Sahm

Nov 22, 2025
pulisher
Nov 20, 2025

Combining machine learning predictions for Immuneering Corporation2025 Technical Overview & Technical Pattern Based Signals - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Best data tools to analyze Immuneering Corporation stockTrend Reversal & Stepwise Trade Execution Plans - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

How Immuneering Corporation stock compares to growth peersLong Setup & Reliable Breakout Stock Forecasts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Immuneering Corporation stock poised for growthBear Alert & Community Trade Idea Sharing - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Does Immuneering Corporation qualify in momentum factor screeningMarket Growth Review & Step-by-Step Trade Execution Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Immuneering Corporation stock reach $100 price targetEntry Point & Long-Term Safe Investment Plans - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Will Immuneering Corporation stock beat EPS estimatesPortfolio Gains Report & High Win Rate Trade Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Can machine learning forecast Immuneering Corporation recoveryMarket Volume Report & Entry Point Confirmation Signals - newser.com

Nov 18, 2025
pulisher
Nov 16, 2025

Is Immuneering Corporation stock undervalued vs historical averages2025 Valuation Update & Real-Time Stock Movement Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

What data driven models say about Immuneering Corporation’s futureMarket Activity Summary & Safe Entry Point Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Why Immuneering Corporation stock is recommended by analystsWeekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Can momentum traders help lift Immuneering CorporationJuly 2025 Analyst Calls & Advanced Technical Analysis Signals - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Immuneering Corporation (NASDAQ:IMRX) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 14, 2025
pulisher
Nov 13, 2025

Immuneering Corp. Shines in Positive Earnings Call - TipRanks

Nov 13, 2025
pulisher
Nov 13, 2025

What momentum indicators show for Immuneering Corporation stockWeekly Stock Report & High Return Trade Guides - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Immuneering rises after smaller-than-expected Q3 loss - TradingView

Nov 13, 2025
pulisher
Nov 13, 2025

Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates - The Manila Times

Nov 13, 2025
pulisher
Nov 12, 2025

Immuneering Corp. Reports Strong Q3 2025 Progress - TipRanks

Nov 12, 2025
pulisher
Nov 12, 2025

Earnings call transcript: Immuneering Q3 2025 emphasizes cash boost and trial progress - Investing.com Nigeria

Nov 12, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):